[go: up one dir, main page]

GB201507100D0 - Method - Google Patents

Method

Info

Publication number
GB201507100D0
GB201507100D0 GBGB1507100.4A GB201507100A GB201507100D0 GB 201507100 D0 GB201507100 D0 GB 201507100D0 GB 201507100 A GB201507100 A GB 201507100A GB 201507100 D0 GB201507100 D0 GB 201507100D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1507100.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Technology Ltd
Original Assignee
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Technology Ltd filed Critical Cancer Research Technology Ltd
Priority to GBGB1507100.4A priority Critical patent/GB201507100D0/en
Publication of GB201507100D0 publication Critical patent/GB201507100D0/en
Priority to PL16718705T priority patent/PL3288581T3/en
Priority to CN202311208886.4A priority patent/CN117467603A/en
Priority to CA2982266A priority patent/CA2982266A1/en
Priority to EP19196028.5A priority patent/EP3603666B1/en
Priority to SG11201707920YA priority patent/SG11201707920YA/en
Priority to JP2017555770A priority patent/JP6918703B2/en
Priority to AU2016256220A priority patent/AU2016256220B2/en
Priority to MX2017013777A priority patent/MX381241B/en
Priority to NZ735882A priority patent/NZ735882A/en
Priority to ES16718705T priority patent/ES2836273T3/en
Priority to DK16718705.3T priority patent/DK3288581T3/en
Priority to RU2020123735A priority patent/RU2020123735A/en
Priority to KR1020237027450A priority patent/KR102884519B1/en
Priority to PCT/EP2016/059401 priority patent/WO2016174085A1/en
Priority to SG10202007364RA priority patent/SG10202007364RA/en
Priority to IL254760A priority patent/IL254760B2/en
Priority to PT167187053T priority patent/PT3288581T/en
Priority to CN201680024518.6A priority patent/CN107750278B/en
Priority to EP22195469.6A priority patent/EP4137151A1/en
Priority to EP19196027.7A priority patent/EP3603665B1/en
Priority to KR1020177034158A priority patent/KR102629590B1/en
Priority to EP16718705.3A priority patent/EP3288581B1/en
Priority to US15/569,334 priority patent/US20180064793A1/en
Priority to HUE16718705A priority patent/HUE052106T2/en
Priority to MYPI2017001511A priority patent/MY189338A/en
Priority to RU2017134504A priority patent/RU2770447C2/en
Priority to BR112017020893-8A priority patent/BR112017020893A2/en
Priority to ZA2017/06616A priority patent/ZA201706616B/en
Priority to CL2017002728A priority patent/CL2017002728A1/en
Priority to US16/565,342 priority patent/US20200000903A1/en
Priority to US16/565,350 priority patent/US20200000904A1/en
Priority to JP2020069210A priority patent/JP2020127404A/en
Priority to CL2020001730A priority patent/CL2020001730A1/en
Priority to JP2021149024A priority patent/JP2022008381A/en
Priority to AU2021286241A priority patent/AU2021286241B2/en
Priority to IL298497A priority patent/IL298497B1/en
Priority to JP2023164102A priority patent/JP2024001069A/en
Priority to AU2025200181A priority patent/AU2025200181A1/en
Ceased legal-status Critical Current

Links

GBGB1507100.4A 2015-04-27 2015-04-27 Method Ceased GB201507100D0 (en)

Priority Applications (39)

Application Number Priority Date Filing Date Title
GBGB1507100.4A GB201507100D0 (en) 2015-04-27 2015-04-27 Method
BR112017020893-8A BR112017020893A2 (en) 2015-04-27 2016-04-27 method for cancer treatment
CN201680024518.6A CN107750278B (en) 2015-04-27 2016-04-27 How to treat cancer
EP22195469.6A EP4137151A1 (en) 2015-04-27 2016-04-27 Method
CA2982266A CA2982266A1 (en) 2015-04-27 2016-04-27 Method for treating cancer
EP19196028.5A EP3603666B1 (en) 2015-04-27 2016-04-27 METHOD FOR IDENTIFYING AND PROVIDING CLONAL NEOANTIGEN-SPECIFIC T CELLS
SG11201707920YA SG11201707920YA (en) 2015-04-27 2016-04-27 Method for treating cancer
JP2017555770A JP6918703B2 (en) 2015-04-27 2016-04-27 How to treat cancer
AU2016256220A AU2016256220B2 (en) 2015-04-27 2016-04-27 Method for treating cancer
MX2017013777A MX381241B (en) 2015-04-27 2016-04-27 Method for treating cancer
NZ735882A NZ735882A (en) 2015-04-27 2016-04-27 Method for treating cancer
ES16718705T ES2836273T3 (en) 2015-04-27 2016-04-27 Cancer treatment method
DK16718705.3T DK3288581T3 (en) 2015-04-27 2016-04-27 CANCER TREATMENT PROCEDURE
RU2020123735A RU2020123735A (en) 2015-04-27 2016-04-27 METHOD FOR TREATMENT OF CANCER
KR1020237027450A KR102884519B1 (en) 2015-04-27 2016-04-27 Method for treating cancer
PCT/EP2016/059401 WO2016174085A1 (en) 2015-04-27 2016-04-27 Method for treating cancer
SG10202007364RA SG10202007364RA (en) 2015-04-27 2016-04-27 Method for treating cancer
IL254760A IL254760B2 (en) 2015-04-27 2016-04-27 A method for treating cancer
CN202311208886.4A CN117467603A (en) 2015-04-27 2016-04-27 Methods of treating cancer
PL16718705T PL3288581T3 (en) 2015-04-27 2016-04-27 METHOD OF TREATMENT OF CANCER
EP19196027.7A EP3603665B1 (en) 2015-04-27 2016-04-27 METHODS FOR PRODUCING PERSONALIZED T-CELLS FOR CANCER TREATMENT
PT167187053T PT3288581T (en) 2015-04-27 2016-04-27 Method for treating cancer
HUE16718705A HUE052106T2 (en) 2015-04-27 2016-04-27 Method of treating cancer
EP16718705.3A EP3288581B1 (en) 2015-04-27 2016-04-27 Method for treating cancer
US15/569,334 US20180064793A1 (en) 2015-04-27 2016-04-27 Method for treating cancer
KR1020177034158A KR102629590B1 (en) 2015-04-27 2016-04-27 How to treat cancer
MYPI2017001511A MY189338A (en) 2015-04-27 2016-04-27 Method for treating cancer
RU2017134504A RU2770447C2 (en) 2015-04-27 2016-04-27 Method for treating cancer
ZA2017/06616A ZA201706616B (en) 2015-04-27 2017-10-02 Method for treating cancer
CL2017002728A CL2017002728A1 (en) 2015-04-27 2017-10-26 Method for cancer treatment
US16/565,342 US20200000903A1 (en) 2015-04-27 2019-09-09 Method for Treating Cancer
US16/565,350 US20200000904A1 (en) 2015-04-27 2019-09-09 Neo-antigen specific t cells
JP2020069210A JP2020127404A (en) 2015-04-27 2020-04-07 Ways to treat cancer
CL2020001730A CL2020001730A1 (en) 2015-04-27 2020-06-24 Method for treating cancer. (divisional request 201702728)
JP2021149024A JP2022008381A (en) 2015-04-27 2021-09-14 Methods for treating cancer
AU2021286241A AU2021286241B2 (en) 2015-04-27 2021-12-13 Method for treating cancer
IL298497A IL298497B1 (en) 2015-04-27 2022-11-23 Method for treating cancer
JP2023164102A JP2024001069A (en) 2015-04-27 2023-09-27 methods to treat cancer
AU2025200181A AU2025200181A1 (en) 2015-04-27 2025-01-10 Method for treating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1507100.4A GB201507100D0 (en) 2015-04-27 2015-04-27 Method

Publications (1)

Publication Number Publication Date
GB201507100D0 true GB201507100D0 (en) 2015-06-10

Family

ID=53488685

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1507100.4A Ceased GB201507100D0 (en) 2015-04-27 2015-04-27 Method

Country Status (1)

Country Link
GB (1) GB201507100D0 (en)

Similar Documents

Publication Publication Date Title
GB201516047D0 (en) Method
GB201502645D0 (en) Method
GB201502810D0 (en) Method
GB201518263D0 (en) Method
GB201517450D0 (en) Method
GB201516056D0 (en) Method
GB201500427D0 (en) Method
GB201501941D0 (en) Method
GB201506870D0 (en) Method
GB201507581D0 (en) Method
GB201506869D0 (en) Method
GB201501565D0 (en) Method
GB201518465D0 (en) Method
GB201517386D0 (en) Method
GB201510649D0 (en) Method
GB201509961D0 (en) Method
GB201503792D0 (en) Method
GB201502409D0 (en) Method
GB201506315D0 (en) Method
GB201518850D0 (en) Method
GB201517618D0 (en) Method
GB201517634D0 (en) Method
GB201515921D0 (en) Method
GB201515714D0 (en) Method
GB201515718D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)